We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+32.65%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.1B
AUM Growth
-$1.29B
Cap. Flow
-$1.61B
Cap. Flow %
-76.67%
Top 10 Hldgs %
43.41%
Holding
94
New
23
Increased
6
Reduced
30
Closed
33

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$63.4M
2
ELV icon
Elevance Health
ELV
+$54.6M
3
CNC icon
Centene
CNC
+$44.4M
4
PFE icon
Pfizer
PFE
+$34.7M
5
ICUI icon
ICU Medical
ICUI
+$28.5M

Top Sells

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$121M
2
PEN icon
Penumbra
PEN
+$97.1M
3
ZBH icon
Zimmer Biomet
ZBH
+$77.5M
4
NXPI icon
NXP Semiconductors
NXPI
+$75.2M
5
MCHP icon
Microchip Technology
MCHP
+$72.3M

Sector Composition

Rank Sector Weight
1 Healthcare 69.54%
2 Technology 2.78%
3 Consumer Discretionary 0.53%
4 Financials 0.1%
5 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICUI icon
26
ICU Medical
ICUI
$4.16B
$31M 1.48%
+165,665
New +$28.5M
HUM icon
27
Humana
HUM
$43.9B
$29.2M 1.39%
+79,546
New +$25.2M
ABT icon
28
Abbott
ABT
$188B
$28M 1.34%
+322,713
New +$27M
UNH icon
29
UnitedHealth
UNH
$382B
$27.8M 1.33%
+94,699
New +$24.8M
VRTX icon
30
CALL
Vertex Pharmaceuticals
VRTX
$123B
$27.6M 1.32%
+126,200
New +$25.5M
BPMC
31
PUT
DELISTED
Blueprint Medicines
BPMC
$27M 1.29%
+336,800
New +$25.2M
NVST icon
32
Envista
NVST
$4.62B
$24.5M 1.17%
+825,732
New +$23.5M
EW icon
33
Edwards Lifesciences
EW
$49.4B
$24.1M 1.15%
309,837
-445,425
-59% -$34.8M
MOH icon
34
Molina Healthcare
MOH
$10.4B
$24M 1.14%
176,964
-314,833
-64% -$39.7M
EXAS
35
DELISTED
Exact Sciences
EXAS
$19.4M 0.92%
+209,839
New +$18.4M
CTLT
36
DELISTED
CATALENT, INC.
CTLT
$17.8M 0.85%
316,962
-789,811
-71% -$40.3M
AXNX
37
DELISTED
Axonics, Inc. Common Stock
AXNX
$15.2M 0.73%
550,026
+298,565
+119% +$7.13M
ABBV icon
38
AbbVie
ABBV
$465B
$14.7M 0.7%
+166,239
New +$13.8M
CSII
39
DELISTED
Cardiovascular Systems, Inc.
CSII
$13.3M 0.64%
274,689
-190,356
-41% -$8.67M
VRTX icon
40
Vertex Pharmaceuticals
VRTX
$123B
$12.5M 0.59%
+56,922
New +$11.5M
AMRN
41
Amarin Corp
AMRN
$297M
$11.4M 0.54%
+26,671
New +$10.1M
LAB icon
42
Standard BioTools
LAB
$342M
$11.3M 0.54%
3,234,984
+125,805
+4% +$443K
MSFT icon
43
Microsoft
MSFT
$2.9T
$11.3M 0.54%
71,367
-179,236
-72% -$26.3M
HALO icon
44
Halozyme
HALO
$9.88B
$10.5M 0.5%
+593,480
New +$10.3M
CRM icon
45
Salesforce
CRM
$154B
$10.3M 0.49%
63,398
-287,024
-82% -$45M
CHRS icon
46
Coherus Oncology
CHRS
$217M
$9.63M 0.46%
535,086
-154,739
-22% -$2.85M
BABA icon
47
Alibaba
BABA
$276B
$9.42M 0.45%
44,411
-36,793
-45% -$6.9M
NVDA icon
48
NVIDIA
NVDA
$4.6T
$9.39M 0.45%
+1,595,560
New +$8.3M
BIIB icon
49
CALL
Biogen
BIIB
$30.9B
$8.99M 0.43%
+30,300
New +$8.41M
MCHP icon
50
Microchip Technology
MCHP
$38.8B
$8.55M 0.41%
163,342
-1,497,646
-90% -$72.3M
1
2
3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q4 2019 Portfolio in Review

As of Q4 2019, PFM Health Sciences held 94 positions worth $2.1B, down 38% from $3.39B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

PFM Health Sciences withdrew a net $1.61B in Q4 2019, closing 33 positions and reducing 30 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $68.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 60% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PFM Health Sciences opened a new position in Biogen worth $67.8M.

  • PFM Health Sciences's largest Q4 2019 buy was Biogen: 228,328 shares worth $67.8M.
  • PFM Health Sciences added most to NEVRO CORP. in Q4 2019, an estimated $17.9M increase.
  • PFM Health Sciences's biggest Q4 2019 reduction was BioMarin Pharmaceuticals, cutting an estimated $121M.
  • PFM Health Sciences fully exited Wellcare Health Plans, Inc. in Q4 2019, selling an estimated $68.3M.
  • PFM Health Sciences's ten largest holdings make up 43% of its $2.1B portfolio in Q4 2019.
  • PFM Health Sciences opened 23 new positions and closed 33 in Q4 2019.
  • PFM Health Sciences's portfolio value fell 38% quarter-over-quarter to $2.1B.

Based on PFM Health Sciences's 13F filing for Q4 2019, filed 14 Feb 2020.